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Rationale
CD103+ DCs (dendritic cells) and CCR9+ pDCs (plas-
macytoid DCs) have been implicated in promoting toler-
ance to antigens through regulatory-T cell induction.
We have conducted food oral immunotherapy (OIT)
clinical studies for the last 3 years at Stanford Univer-
sity. We hypothesized that subjects with food allergies
have low CD103+ and CCR9+ expression on their DCs
but that these DC populations change over time while
on therapy.
Methods
OIT was conducted and blood samples were drawn at
baseline and approximately every 5 months during the
study. The study is currently ongoing. PBMCs (periph-
eral blood mononuclear cells) were purified and flow
cytometry was performed on gated DCs (LSRII, BD
Biosciences).
Results
DCs expressing CD103 (integrin-alpha E) and CCR9
(CCL25 chemokine receptor) were examined in three
cohorts - (1) patients undergoing milk or peanut OIT
(n=8), (2) healthy controls (HC) (n=8), and (3) non-OIT
food allergy patients (FA) (n=8). PBMCs were incubated
for 6 or 18 hours either with or without offending aller-
gen. CCR9+ expression on pDCs was significantly
greater in HC versus FA patients (42%±25% vs 11%
±10%; p <0.01) while CD103 expression on DCs was
comparatively greater in HC versus FA patients (0.19%
±0.17% vs 0.07%±0.07%; p=0.16). After offending aller-
gen stimulation for both 6 and 18 hours, CCR9 presence
on pDCs significantly increased more in FA patients
than in HC patients (213MFI*-6hr, 188MFI-18hr versus
12MFI for HC; p<0.03). In OIT patients, CCR9 change
on pDCS after stimulation was significantly different
than their baseline CCR9 MFI shift values (16MFI ver-
sus 188MFI; p<0.03) and more in line with the HC pro-
file. *-Median Fluorescent Intensity.
Conclusion
The CCR9 and CD103 DC populations may play an
important role for food allergy patients undergoing OIT.
These tolerogenic DC changes in OIT may reveal one
way that regulatory T-cell mediated tolerance, T-cell
anergy, and/ or clonal deletion is induced.
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